Genetic Correlation of Community-Associated Methicillin-Resistant Staphylococcus aureus Strains from Carriers and from Patients with Clinical Infection in One Region of Korea by Bae, In-Gyu et al.
INTRODUCTION
Since the 1980s, methicillin-resistant Staphylococcus aureus
(MRSA) infections have become a serious clinical problem
among hospitalized patients worldwide. In Korea, the fre-
quency of methicillin resistance among S. aureus isolates from
Korean tertiary-care hospitals was reported to account for
more than 70% of all cases in 2003 (1). Since the first case
of community-associated methicillin-resistant S. aureus (CA-
MRSA) infection was reported in the United States in 1980
(2), recent studies have reported that CA-MRSA infections
appeared to be on the increase in both adults and children
in various regions and countries (3-8). CA-MRSA isolates
in the United States and Australia have been reported to pos-
sess a novel staphylococcal cassette chromosome mec (SCCmec)
type, type IV, and frequently contain a gene coding for Pan-
ton-Valentine leukocidin (PVL) (9). 
Colonizing S. aureus strains may serve as the causative pa-
thogen for overt clinical infections and may spread to other
patients in a hospital (10). Nasal S. aureus carriage has been
identified as a risk factor for the pathogenesis of communi-
ty-acquired and nosocomial infection (11). However, previ-
ous studies have not examined the genetic relationship bet-
ween S. aureus strains from patients with clinical infections
and strains from colonized individuals in the community.
Recently, molecular typing techniques such as pulsed-
field gel electrophoresis (PFGE), multilocus sequence typ-
ing (MLST), and spa (staphylococcal protein A) typing have
been used to document the local and global epidemiology
of MRSA isolates (12-15). PFGE has been used the most
widely, but the results obtained from different laboratories
often can not be compared (16). Therefore DNA sequence
typing, including MLST and spa typing, has become more
popular (17). In this study, we evaluated the genetic relation-
ship between CA-MRSA strains from carriers and those from
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Genetic Correlation of Community-Associated Methicillin-Resistant
Staphylococcus aureus Strains from Carriers and from Patients with
Clinical Infection in One Region of Korea
Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) is
an increasingly common worldwide and colonizing S. aureus strains may serve as
the causative pathogen for overt clinical infections. This study was performed to
determine whether the pathogenic CA-MRSA isolate in clinical infections was geneti-
cally related to the MRSA isolates in community carriers. We prospectively collect-
ed a total of 42 CA-MRSA isolates (23 clinical infection isolates and 19 colonization
isolates) in a local region of Korea. Antimicrobial susceptibility tests, staphylococcal
toxin assays, SCCmec typing, multilocus sequence typing (MLST), and spa (staphy-
lococcal protein A) typing were performed with all isolates. Thirty-four (81%) of 42
CA-MRSA isolates belonged to sequence type (ST) 72 in the MLST analysis. The
distribution of STs did not differ significantly between colonization and clinical infec-
tion isolates (89.5% [17/19] vs. 73.9% [17/23], P=0.26). Among the ST72-MRSA
isolates, spa type t664 (18, 52.9%) and t324 (8, 23.5%) were common in both groups.
This study demonstrates that the community-associated MRSA strains from patients
with clinical infections are closely related to the strains found in carriers from one
local community.
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Study design and case definition
We had prospectively collected all MRSA isolates from
2004 through 2006 in a tertiary care hospital in Gyeongsang
Province, Korea. All isolates were obtained from patients
who were admitted to the hospital or from individuals who
visited the Health Promotion Center of this hospital. MRSA
isolates were considered to be community-associated if the
isolate was obtained from a patient who had no risk factors
for health care-associated infection and the sample was col-
lected within 72 hr of admission. Established risk factors for
health care-associated infection included a history of hospi-
talization, surgery, dialysis, or residence in a long-term care
facility within one year prior to the MRSA_culture date, or
the presence of a permanent indwelling catheter or medical
device (e.g. tracheostomy tube, gastrostomy tube, or Foley
catheter) at the time of the culture collection (6). Clinical
infection was assumed if a patient with an MRSA isolate pre-
sented with clinical manifestations of staphylococcal infec-
tion in the bloodstream, central nervous system, bone, joints,
lungs, pleural fluid, muscle, skin, or soft tissue. Colonization
was assumed if the MRSA was isolated from a patient lack-
ing clinical signs and symptoms of a staphylococcal infection
or from an individual who was screened for MRSA carriage
from the anterior nares or throat in the Health Promotion
Center.
Antimicrobial susceptibility tests 
Antimicrobial susceptibility testing was performed at 35℃
on Mueller-Hinton agar by the disk diffusion method, and
the results were interpreted using Clinical and Laboratory
Standards Institute (CLSI) breakpoint criteria (18). All strains
were tested for the presence of the mecA gene by a multiplex
PCR (determined using the two PCR methods described
below).
Polymerase chain reaction analysis of toxin and
SCCmec typing 
Genomic DNAs of S. aureus were prepared using the Qia-
gen DNA Minikit (Qiagen, Hilden, Germany), according
to the manufacturer’s recommendations. PCR amplification
for the staphylococcal enterotoxin genes (sea, seb, sec, sed, and
see), toxic shock syndrome toxin gene (tst), exfoliative toxin
genes (eta and etb), and PVL gene (pvl) was performed as pre-
viously reported (19). SCCmec typing was performed using
the multiplex PCR method of Oliveira and de Lencastre (20).
This SCCmec typing method can amplify nine different genes
in one reaction, and subtypes are determined by the presence
or absence of these genes. 
MLST and spa typing
MLST was performed as described previously (12). PCR
fragments of the seven housekeeping genes (arcC, aroE, glpF,
gmk,pta,tpi, and yqiL) were obtained from chromosomal DNA
and were directly sequenced. The allelic profiles of the S. aureus
strains were defined on the basis of their MLST type. Each
unique allelic profile was designated a sequence type (ST),
which was determined using the database at the MLST web-
site (http://saureus.mlst.net/). 
Spa typing was performed as previously described (21).
DNA sequences were obtained with an ABI 377 Sequencer
(Applied Biosystems, Foster City, CA, USA). spa types were
determined using the database at the Ridom SpaServer web-
site (http://spa.ridom.de/ spatype s.shtml).
RESULTS
CA-MRSA isolates
A total of 42 non-duplicated CA-MRSA isolates were col-
lected from 2004 through 2006: 12 isolates from 2004, 12
isolates from 2005, and 18 isolates from 2006 (Fig. 1). Of
these 42 isolates, 19 were collected from the clinical specimens
of patients without clinical signs and symptoms of staphy-
lococcal infection (n=10: 6 from urine and 4 from sputum)
and from the MRSA screening culture samples from the throat
or anterior nares (n=9: 5 from throat swab and 4 from nasal
swab). Twenty-three isolates were taken from patients with
clinical MRSA infections: skin and soft-tissue infection (n=8),
bacteremia (n=6), urinary tract infection (n=2), pneumonia
(n=2), and other clinical infections (n=5).
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Fig. 1. Enrollment of community-acquired methicillin-resistant
Staphylococcus aureus isolates.
*This is the percentage of MRSA isolates among all S. aureus
isolates.
HPC, Health promotion center; ES, Elementary school.
CA-MRSA isolates with
clinical infection (n=23)
MRSA isolates from clinical
specimens (n=3,389, 79.2%*)
MRSA isolates from surveillance
culture (n=9)
- nasal swab of adults in HPC (n=4)






isolates (n=19)Toxin gene profiles of CA-MRSA isolates
The majority of the 42 CA-MRSA isolates did not have
any toxin genes. The sea was detected in 2 clinical infection
isolates with ST239 clone and 2 isolates (1 clinical infection
and 1 colonization isolate) with ST1 clone. The tst was detect-
ed in 1 clinical infection isolate with ST5 clone. The pvl was
not detected in any of the isolates. 
Genotyping and SCCmec typing of CA-MRSA isolates
The MLST analysis of the 42 CA-MRSA isolates revealed
five ST types, including ST72, ST1, ST5, ST239 and ST89.
The most prevalent ST was ST72 (34/42, 81%). The inci-
dence of ST72 in clinical infection isolates was similar to that
in colonization isolates (73.9% [17/23] vs. 89.5% [17/19]).
There were seven spa types in our ST72-MRSA isolates: t664,
UJGGMDMGM (n=18, 52.9%); t324, UJGGMDMGGM
(n=8, 23.5%); t901, UJGMDMGGM (n=2, 5.9%); t2473,
UJGFGM (n=1, 2.9%); undetermined type (UT), UJGGM
(n=3, 8.8%); UT, UJGGMDMGGMM (n=1, 2.9%); and
UT, UJGGDMGM (n=1, 2.9%). These ST72-MRSA iso-
lates showed deletion-insertion events in spa, which gener-
ated seven spa types (Table 1). ST5 and ST239 clones were
detected in 4 isolates from only clinical infection group; the
spa type of two ST5-MRSA isolates was t002, TJMBMD-
MGMK, and that of the two ST239-MRSA isolates was t37,
WGKAOMQ. Three isolates (2 from blood and 1 from urine)
which were obtained from neonates who were less than 30
days of age had ST1-MRSA-IV, spa type t286, UJEBKBPE. 
The SCCmec types identified in the CA-MRSA isolates
included: type IVa (n=30, 71.4%), IV (n=8, 19.5%), III (n=
2, 4.8%), II (n=1, 2.4%), and IIa (n=1, 2.4%). There were
four different SCCmec types (IVa, II, III, and IV) in the patho-
genic isolates and type IVa predominated (65.2%). Of 19
colonization isolates, there were three SCCmec types (types
IVa, IV, and IIa) and the most common type was also type
IVa (78.9%). ST72 MRSA strains, which predominated in
all CA-MRSA isolates in this study, were SCCmec type IVa
or IV, and the majority of them were SCCmec type IVa (29
of 34, 85.3%). 
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*ST determined based on the MLST website (http://saureus.mlst.net); 
�
Nomenclature according to Shopsin et al. (21); 
�
Nomenclature according to
Harmsen et al. (13).















No. (%) of isolates
ST72 t664 UJGGMDMGM IVa 16 (38.1) 8 (34.8) 8 (42.1) 0.75
IV 2 (4.8) 1 (4.3) 1 (5.3) 1.00
t324 UJGGMDMGGM IVa 6 (14.3) 1 (4.3) 5 (26.3) 0.07
IV 2 (4.8) 1 (4.3) 1 (5.3) 1.00
t901 UJGMDMGGM IVa 2 (4.8) 2 (8.7) 0 0.49
t2473 UJGFGM IVa 1 (2.4) 1 (4.3) 0 1.00
UT UJGGM IVa 3 (7.1) 2 (8.7) 1 (5.3) 1.00
UT UJGGMDMGGMM IVa 1 (2.4) 0 1 (5.3) 0.45
UT UJGGDMGM IV 1 (2.4) 1 (4.3) 0 1.00
ST1 t286 UJEBKBPE IV 3 (7.1) 2 (8.7) 1 (5.3) 1.00
ST239 t37 WGKAOMQ III 2 (4.8) 2 (8.7) 0 0.49
ST5 t002 TJMBMDMGMK II 1 (2.4) 1 (4.3) 0 1.00
IVa 1 (2.4) 1 (4.3) 0 1.00
ST89 t375 Y2EJCMBPB IIa 1 (2.4) 0 1 (5.3) 0.45
Table 1. Genotypic characteristics between clinical infection and colonization isolates of CA-MRSA
CIP, ciprofloxacin; CLI, clindamycin; ERY, erythromycin; GEN, gentam-
icin; RIF, rifampin; TET, tetracycline; SXT, trimethoprim-sulfamethoxa-
zole; VAN, vancomycin; S, susceptible.
Antimicrobial
agent












CIP 3 (7.1) 3 (13.0) 0 0.24
CLI 2 (4.8) 1 (4.3) 1 (5.3) 1.00
ERY 25 (59.5) 14 (60.9) 11 (57.9) 1.00
GEN 6 (14.3) 4 (17.4) 2 (10.5) 0.67
RIF 0 0 0 1.00
TET 3 (7.1) 3 (13.0) 0 0.24
SXT 1 (2.4) 1 (4.3) 0 1.00
VAN 0 0 0 1.00
S to all agents 17 (40.5) 9 (39.1) 8 (42.1) 1.00
Table 2. Antimicrobial susceptibility pattern rates of 42 CA-MRSA
isolatesAntimicrobial susceptibility pattern 
The overall rates of resistance to erythromycin, gentamicin,
ciprofloxacin, tetracycline, clindamycin, and trimethoprim-
sulfamethoxazole among the CA-MRSA isolates were 59.5%,
14.3%, 9.5%, 7.1%, 4.8%, and 2.4%, respectively. None of
the isolates were resistant to rifampin or vancomycin. The
majority (85.7%) of the CA-MRSA isolates from both groups
were susceptible to all antimicrobial agents we tested, or were
only resistant to erythromycin. The resistance rates for each
antimicrobial agent did not differ significantly between groups
(Table 2). 
DISCUSSION
Molecular methods have demonstrated a close relationship
between those CA-MRSA strains causing clinical infection
and strains from colonized individuals who represent the pre-
valent CA-MRSA clone in one Korean community.
There are distinct genetic backgrounds of CA-MRSA asso-
ciated with each geographic origin and the molecular types
of CA-MRSA strains do not correspond to those of HA-MRSA
within each continent (5). MLST and spa type analyses have
indicated that there are CA-MRSA strains with ST30 in Aus-
tralian and South American isolates, ST80 in European and
Middle Eastern isolates, ST59 in Taiwanese isolates, and ST1
ST8 and ST59 in the USA isolates (5, 22). 
Recently, a report on CA-MRSA infections in Korea show-
ed that the ST72-MRSA-IVa, spa types t664 and t324, were
found in the CA-MRSA isolates from children and adults
who visited an outpatient clinic in one local region of Korea
with diverse staphylococcal infections, even though those
clones were not dominant in that report (23). Another study
in Korea showed that ST72-MRSA-IVa clones were most
common in the MRSA strains isolated from seven commu-
nity-based or tertiary hospitals (24). The current study has
revealed that ST72-MRSA-IVa, spa types t664 and t324 clones
form a large majority of the CA-MRSA isolates, and they are
found in various clinical isolates regardless of age, sex, isola-
tion site, or whether the isolate was accompanied by the clin-
ical manifestations of MRSA infection or not. 
ST72 strains already have been found in a few HA-MRSA
isolates from one tertiary care hospital in Korea (25). The ST72-
HA-MRSA strains had a genetic background that was iden-
tical in terms of molecular typing to the ST72-CA-MRSA
strains from the isolates collected in the outpatient clinic (25).
A Swedish report recently noted that MRSA isolates with
ST72-MRSA-IVa, spa types t664 and t324, were found in
screening culture samples of young children from Korea adopt-
ed by Swedish families; all adoptees had a history of hospital-
ization in their native country before arriving in Sweden (26).
Whether the ST72-MRSA strains originated in a community
or hospital setting, they are now widely distributed in the
community in Korea; all ST72-MRSA strains from previous
studies and our study were collected in the community.
In 2006, it was reported that ST1-MRSA-IVa, spa type
t286, was detected in MRSA isolates from neonates between
1 and 13 days of age, who were transferred from 2 primary
obstetrics clinics to a tertiary care hospital in Seoul, Korea
(27). ST1-MRSA isolates detected in our study were also ob-
tained from neonates and were spa type t286 clones, even
though their SCCmec type (type IV) was different from that
of the MRSA isolates detected in the previous study. These
findings suggest that ST1-MRSA, spa type t286, might be
distributed in the community in Korea, and primary obstet-
rics clinics may be a reservoir for this MRSA clone. 
ST5 and ST239 isolates, which are known to be the dom-
inant genotype of HA-MRSA isolates in Korea, were detect-
ed in 4 clinical infection isolates in our study. The patients
with these isolates had no risk factors for health care-associ-
ated infection in their medical records. We suggest that these
ST5 and ST239-MRSA clones may have originated in a hos-
pital reservoir and then spread in the community. 
The pvl represents a stable marker of CA-MRSA strains,
which is a possible virulence factor associated with necrotic
lesions of the skin and subcutaneous tissue (e.g. furuncles) and
also with community-acquired severe necrotic pneumonia
(9, 28). However, none of the CA-MRSA isolates harbored
pvl in our study. This observation is consistent with previous
Korean studies (23, 24). 
There are several limitations to the current study. First, this
investigation was performed at a single tertiary health care
center. Therefore, the findings may not be generalized to other
regions of Korea. Nevertheless, our data shows a close genet-
ic relationship between CA-MRSA isolates causing clinical
infection and the colonized isolates in a local community.
Second, our subjects were patients hospitalized in a tertiary
care hospital. Thus, generalization of these findings to other
populations, especially to patients treated at outpatient clin-
ics in the community, should be done with caution. Third,
we analyzed only a relatively small number of CA-MRSA
isolates. This might be caused by the relative low incidence
rate of CA-MRSA infection in Korea, contrary to our expec-
tation. A small data set may introduce sampling bias, so the
findings of this study should not be generalized to the entire
population of Korea until additional data are available. 
In conclusion, our study shows that CA-MRSA strains from
patients with clinical infection are genotypically similar to
those from colonized individuals and ST72-MRSA-IVa, spa
types t664 and t324, which are different from the HA-MRSA
clones previously reported in Korea, were the prevalent clones
among the CA-MRSA isolates collected in one region of Korea.
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